Escalon Medical Corp. (ESMC)
OTCMKTS · Delayed Price · Currency is USD
0.2700
-0.0400 (-12.90%)
Aug 22, 2025, 4:00 PM EDT
Escalon Medical Revenue
Escalon Medical had revenue of $3.47M in the quarter ending March 31, 2025, with 28.89% growth. This brings the company's revenue in the last twelve months to $12.95M, up 11.18% year-over-year. In the fiscal year ending June 30, 2024, Escalon Medical had annual revenue of $11.98M, down -1.63%.
Revenue (ttm)
12.95M
Revenue Growth
+11.18%
P/S Ratio
0.15
Revenue / Employee
323.70K
Employees
40
Market Cap
2.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 11.98M | -198.71K | -1.63% |
Jun 30, 2023 | 12.18M | 1.48M | 13.80% |
Jun 30, 2022 | 10.70M | 231.45K | 2.21% |
Jun 30, 2021 | 10.47M | 1.07M | 11.40% |
Jun 30, 2020 | 9.40M | -226.63K | -2.35% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Glass House Brands | 221.55M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |